Email Sign-Up Go to Shopping Cart (0)
 
 
EVERYDAY LOW PRICES ON PET SUPPLIES - 100% SATISFACTION GUARANTEE - FREE SHIPPING on orders $49 or more*
HOME »    ARTICLES »    PHARMACY »    MEDICATION SPOTLIGHTS »    PHARMACY SPOTLIGHT: COMFORTIS®
Save Time! Download our Prescription Fax Form PDF before you go to the veterinarian
Our Heartworm
Guarantee
Flea & Tick
No prescription required for Flea & Tick Control
Horses
Ferrets
Ordering Information
Full Prescription
Product List
Veterinarians
FREE Prescription Resource Guides
Pharmacy Articles
About Our Pharmacy
1-800-447-3021
Disposal of Unused Medicines
Disposal of Needles and Other Sharps
Safe Handling of Contaminated Materials
Pharmacy Privacy Policy

Pharmacy Spotlight: Comfortis®


Drs. Foster & Smith Educational Staff
TOP VIEWED ARTICLES
Pharmacy Spotlight: Ketoconazole (Nizoral) 
Pharmacy Spotlight: Vetmedin® for Dogs 
Pharmacy Spotlight: Corticosteroids 
PRODUCTS RELATED TO:
Medication Spotlights
Ketoconazole (Generic)
Ketoconazole (Generic)
As low as $1.49
Comfortis Chewable Tablets (Brand)
Comfortis Chewable Tablets (Brand)
As low as $87.99
Slentrol Oral Solution (Brand)
Slentrol Oral Solution (Brand)
As low as $26.99
Spotlight on Comfortis

  • Medication type: Prescription-only insecticide derived from the naturally occurring bacterium Saccarapolyspora spinosa

  • Active ingredient: Spinosad

  • Dosage form: Monthly chewable tablets Flea Cycle

  • Manufacturer: Elanco

  • Generic Form: None

  • Major use: To kill fleas on dogs and prevent flea infestations for one month.

  • How it works: Saccarapolyspora spinosa interferes with the insect's neurotransmitters, causing the insect's paralysis and death. This medication eliminates existing infestations and prevents further infestations for one month.

Comfortis® SUCCESS STORY:

Dog's Name: Georgie
Mixed BreedBreed: Female Mixed Breed
Age: 2 years

Her story: After a job-related move to Texas from a colder, northern climate, Georgie's owners found themselves dealing with a major flea problem. Not only were there more wild, roaming small animals in their new rural neighborhood, the folks next door had several cats and dogs that loved to visit Georgie. This scenario created a flea heaven in her backyard.

But it was no heaven for Georgie. The blood-sucking parasites made her life miserable. She began to scratch incessantly, and the owners tried many different products. They gave their dog regular baths and spent much time brushing her with a flea comb. But the fleas kept winning out. On a visit to their vet, they learned about a new medication, Comfortis®, the first FDA-approved, chewable, beef-flavored tablet that is effective in killing fleas and preventing infestations on dogs for a full month. The vet explained that the fleas start dying within thirty minutes, and that the active ingredient, Spinosad, is actually environmentally friendly.

Outcome: Georgie's owners were desperate, so they were eager to try the new medication. Within a short time of chewing the first tablet, several fleas fell off their dog and expired! In no time at all, Georgie's demeanor was totally improved. She had regained her former state of comfortable canine existence, something every dog is entitled to! Because Georgie lives in an area where fleas are common year-round, treatment with Comfortis™ will continue throughout the year. At their veterinarian's suggestion, the owners implemented the very practical measures of spraying the backyard and limiting the dog's exposure to areas of known flea infestation.

The veterinarian cautioned them to watch or vomiting, decreased appetite, lethargy, redness of the skin, hyperactivity, and excessive salivation, but, to date, there have been no signs of adverse reactions other than, perhaps, a slight decrease in the dog’s appetite. All in all, Georgie is faring well, and her owners, likewise, are enjoying the benefits of Comfortis™!

For full details on this medication, download the free patient information sheet.

Click here for a more printer-friendly version of this article.  
Click here for a pdf version of this article.  

 

 



Contact us